HK1060971A1 - Parenteral dosage forms comprising a suspension oftramadol salt and diclofenac salt - Google Patents

Parenteral dosage forms comprising a suspension oftramadol salt and diclofenac salt

Info

Publication number
HK1060971A1
HK1060971A1 HK04103826A HK04103826A HK1060971A1 HK 1060971 A1 HK1060971 A1 HK 1060971A1 HK 04103826 A HK04103826 A HK 04103826A HK 04103826 A HK04103826 A HK 04103826A HK 1060971 A1 HK1060971 A1 HK 1060971A1
Authority
HK
Hong Kong
Prior art keywords
salt
suspension
dosage forms
oftramadol
parenteral dosage
Prior art date
Application number
HK04103826A
Other languages
English (en)
Inventor
Johannes Bartholomaeus
Heinrich Kugelmann
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HK1060971A1 publication Critical patent/HK1060971A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04103826A 2000-11-28 2004-05-28 Parenteral dosage forms comprising a suspension oftramadol salt and diclofenac salt HK1060971A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10059020A DE10059020A1 (de) 2000-11-28 2000-11-28 Parenteral applizierbare Darreichungsformen
PCT/EP2001/013789 WO2002043723A1 (de) 2000-11-28 2001-11-27 Parental applizierbare darreichungsformen enthaltend eine suspension des salzes aus tramadol und diclofenac

Publications (1)

Publication Number Publication Date
HK1060971A1 true HK1060971A1 (en) 2004-09-03

Family

ID=7664956

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103826A HK1060971A1 (en) 2000-11-28 2004-05-28 Parenteral dosage forms comprising a suspension oftramadol salt and diclofenac salt

Country Status (13)

Country Link
US (1) US6875447B2 (zh)
EP (1) EP1368016B1 (zh)
JP (1) JP4188084B2 (zh)
CN (1) CN100384410C (zh)
AT (1) ATE323477T1 (zh)
AU (1) AU2002224896A1 (zh)
CY (1) CY1105625T1 (zh)
DE (2) DE10059020A1 (zh)
DK (1) DK1368016T3 (zh)
ES (1) ES2262703T3 (zh)
HK (1) HK1060971A1 (zh)
PT (1) PT1368016E (zh)
WO (1) WO2002043723A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2061599A4 (en) * 2005-08-24 2014-01-22 Telechemistry Oy METHOD FOR TESTING A LIQUID SAMPLE, TEST UNIT AND AUTOMATED SYSTEM OF A PLURALITY OF TEST UNITS
EP2128123A4 (en) 2007-01-29 2011-04-20 Medrx Co Ltd NON-STEROIDAL ANTI-INFLAMMATORY SALT AND ORGANIC AMINO COMPOUND AND USE THEREOF
WO2009090272A1 (es) 2008-01-14 2009-07-23 Biokit, S.A. 'dispositivo para distribuir partículas en un fluido y procedimientos para ello
AU2013204763B2 (en) * 2008-01-14 2015-06-04 Biokit, S.A. Device for distributing particles in a fluid and methods therefor
EP2281558A1 (en) * 2009-08-06 2011-02-09 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors
JP2013535438A (ja) * 2010-07-12 2013-09-12 ユン シン ファーマシューティカル インダストリアル カンパニー，リミティド トラマドールのジクロフェナク塩
WO2012142273A1 (en) 2011-04-12 2012-10-18 Revogenex Inc. Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US10022321B2 (en) 2016-06-30 2018-07-17 Revogenex Ireland Ltd. Intravenous administration of tramadol

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016273A (en) * 1975-07-16 1977-04-05 American Cyanamid Company Sustained release forms of certain oxazepines for parenteral administration
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
SG80535A1 (en) * 1991-09-06 2001-05-22 Mcneilab Inc Composition comprising a tramadol material and acetaminophen and its use
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
DE69508985T2 (de) * 1994-02-21 1999-08-19 Takeda Chemical Industries Ltd Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
WO1996010389A1 (de) * 1994-09-30 1996-04-11 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische zusammensetzung
WO1998050075A1 (en) * 1997-05-07 1998-11-12 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
EP1146905A1 (en) * 1998-11-12 2001-10-24 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
WO2000029022A1 (en) * 1998-11-12 2000-05-25 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
AU768022B2 (en) * 1999-05-27 2003-11-27 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof

Also Published As

Publication number Publication date
JP2004514692A (ja) 2004-05-20
WO2002043723A1 (de) 2002-06-06
AU2002224896A1 (en) 2002-06-11
US20030203037A1 (en) 2003-10-30
EP1368016B1 (de) 2006-04-19
DE50109572D1 (de) 2006-05-24
PT1368016E (pt) 2006-08-31
JP4188084B2 (ja) 2008-11-26
CN100384410C (zh) 2008-04-30
EP1368016A1 (de) 2003-12-10
ATE323477T1 (de) 2006-05-15
DK1368016T3 (da) 2006-07-31
ES2262703T3 (es) 2006-12-01
DE10059020A1 (de) 2002-05-29
US6875447B2 (en) 2005-04-05
CY1105625T1 (el) 2010-12-22
CN1477955A (zh) 2004-02-25

Similar Documents

Publication Publication Date Title
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
PL350453A1 (en) N−cyanomethyl amides as protease inhibitors
GEP20074047B (en) Pramipexole once-daily dosage form
IL154012A0 (en) Hydrogel-driven drug dosage form
WO2001078698A3 (en) Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
PT1441705E (pt) Sistemas terapêuticos sólidos, estabilizados, de libertação rápida e/ou modificada para a administração oral de princípios ativos, excipientes ou produtos alimentares líquidos
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
CY1105625T1 (el) Παρεντερικα χορηγησιμες μορφες χορηγησης που περιεχουν ενα αιωρημα του αλατος απο τραμαδολη και diclofenac
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
PT1404304E (pt) Comprimido contendo cetirizina e pseudoefedrina
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
RS53804A (en) Parenteral composition of paracetamol
ID27771A (id) Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu
IL150528A0 (en) Ibuprofen containing active agent preparation
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
IL158186A0 (en) Pharmaceutically active compounds and methods of use
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
BG106151A (en) Pharmaceutical complex
IL152646A0 (en) Dosage of transdermal delivery systems
MXPA05005326A (es) Tableta que comprende efletirizina y pseudoefedrina.
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
MY120631A (en) Novel pharmaceutical combination having analgesic activity
SI1368016T1 (sl) Dajalne oblike, ki se jih da dajati parenteralno,ki vsebujejo suspenzijo soli iz tramadola in diklofenaka

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131127